Improving asthma control with clinical pharmacist intervention
The Impact of Clinical Pharmacist Intervention on Asthmatic Patient's Outcomes at the University of Gondar Comprehensive and Specialized Hospital, Northwest Ethiopia, 2022: A Randomized Controlled Trial
This study tests if working with clinical pharmacists can help people with asthma manage their condition better than just standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 122 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Gondar Academic / other |
| Locations | 1 site (Gondar) |
| Trial ID | NCT05933369 on ClinicalTrials.gov |
What this trial studies
This trial aims to evaluate the effectiveness of clinical pharmacist-led interventions over three months in improving asthma control among patients compared to standard care. Participants in the intervention group will receive tailored support and education from clinical pharmacists at the start of the study and during follow-up visits at one, three, and six months. The study addresses the high rates of poorly controlled asthma and non-adherence to treatment by integrating clinical pharmacists into patient care. By generating evidence on the impact of these interventions, the study seeks to highlight the value of clinical pharmacists in enhancing patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older with a physician's diagnosis of asthma.
Not a fit: Patients with seasonal asthma, serious communication difficulties, or those with terminal illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve asthma control and overall health outcomes for patients with asthma.
How similar studies have performed: Previous studies have indicated that clinical pharmacist interventions can improve patient outcomes in asthma management, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of 18 years or older * Physician's diagnosis of asthma Exclusion Criteria: * Participation in another asthma education program * Pregnancy * Communication difficulties * Seasonal asthma (asthma symptoms that only occur in a seasonal pattern) * Other pathologies such as COPD, emphysema, lung cancer, respiratory infection * Terminal illness (any disease that is reasonably expected to result in the patient's death) * Having an asthma control test level of \<15 (indicating seriously uncontrolled asthma; for ethical reasons, these patients will be immediately referred ) or * Having an asthma control test level equaling 25 (indicating complete asthma control; no room for improvement) will be excluded from the study.
Where this trial is running
Gondar
- University of Gondar Specialized and Comprehensive Hospital — Gondar, Ethiopia (Recruiting)
Study contacts
- Principal investigator: Eden A Mehari, Msc — University of Gondar
- Study coordinator: Eden A Mehari, Msc
- Email: edenabetu@gmail.com
- Phone: +251988214167
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.